Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice.
暂无分享,去创建一个
I. Tesseur | F. van Leuven | D. Moechars | F. Leuven | C. Van den Haute | K. Spittaels | F Van Leuven | D Moechars | I Tesseur | J Van Dorpe | K Spittaels | C Van den Haute | C. V. Haute | J. Dorpe | J. van Dorpe
[1] D. Carmelli,et al. Lower Cognitive Performance in Normal Older Adult Male Twins Carrying the Apolipoprotein E ε4 Allele , 1994 .
[2] M. Gearing,et al. Aβ‐peptide length aid apolipoprotein E genotype in Alzheimer's disease , 1996 .
[3] E Brisch,et al. The Inhibitory Effect of Apolipoprotein E4 on Neurite Outgrowth Is Associated with Microtubule Depolymerization (*) , 1995, The Journal of Biological Chemistry.
[4] R. Mahley,et al. Stable Expression and Secretion of Apolipoproteins E3 and E4 in Mouse Neuroblastoma Cells Produces Differential Effects on Neurite Outgrowth (*) , 1995, The Journal of Biological Chemistry.
[5] T. Iwatsubo,et al. Somatodendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex , 1997, Neuroreport.
[6] R. Mahley,et al. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.
[7] M. Goedert,et al. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. , 1995, The EMBO journal.
[8] E. Hall,et al. Induction of apolipoprotein E mRNA in the hippocampus of the gerbil after transient global ischemia. , 1996, Brain research. Molecular brain research.
[9] L. Thal,et al. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant , 1996, Neurology.
[10] A. Fagan,et al. Apolipoprotein E-containing High Density Lipoprotein Promotes Neurite Outgrowth and Is a Ligand for the Low Density Lipoprotein Receptor-related Protein* , 1996, The Journal of Biological Chemistry.
[11] M. Tolar,et al. Neurite Degeneration Elicited by Apolipoprotein E Peptides , 1994, Experimental Neurology.
[12] B. Bahr,et al. Age‐Related Phosphorylation and Fragmentation Events Influence the Distribution Profiles of Distinct Tau Isoforms in Mouse Brain , 1998, Journal of neuropathology and experimental neurology.
[13] Jean-Claude Martinou,et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia , 1994, Neuron.
[14] B. Hyman,et al. A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the epsilon 4 allele , 1996, Neurology.
[15] The −491A/T polymorphism of the Apolipoprotein E gene is associated with the ApoEϵ4 allele and Alzheimer's Disease , 1999, Neuroscience Letters.
[16] Thomas Wisniewski,et al. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.
[17] M. Pericak-Vance,et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[18] D. Michaelson,et al. Phosphorylation of tau in apolipoprotein E-deficient mice , 1995, Neuroscience Letters.
[19] D. Michaelson,et al. Site‐Specific Dephosphorylation of Tau of Apolipoprotein E‐Deficient and Control Mice by M1 Muscarinic Agonist Treatment , 1999, Journal of neurochemistry.
[20] S. K. Malhotra,et al. Reactive astrocytes: cellular and molecular cues to biological function , 1997, Trends in Neurosciences.
[21] A. Delacourte,et al. ApoE Synthesis in Human Neuroblastoma Cells , 1997, Neurobiology of Disease.
[22] J. Gilbert,et al. Specific regional transcription of apolipoprotein E in human brain neurons. , 1999, The American journal of pathology.
[23] M. Pericak-Vance,et al. Apolipoprotein E Is Present in Hippocampal Neurons without Neurofibrillary Tangles in Alzheimer's Disease and in Age-Matched Controls , 1994, Experimental Neurology.
[24] L. Mucke,et al. Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: In vivo comparison of distinct GFAP‐lacZ transgenes , 1995, Glia.
[25] A. Berns,et al. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[26] H. Braak,et al. Evolution of the neuropathology of Alzheimer's disease , 1996, Acta neurologica Scandinavica. Supplementum.
[27] J. Schwankhaus,et al. A closely linked gene to apolipoprotein E may serve as an additional risk factor for Alzheimer's disease , 1995, Neuroscience Letters.
[28] A. Smith,et al. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease , 1995, Neuroscience.
[29] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[30] J. Brion,et al. Phosphorylation of tau protein is not affected in mice lacking apolipoprotein E. , 1995, Neuroreport.
[31] R. Demattos,et al. A Test of the Cytosolic Apolipoprotein E Hypothesis Fails to Detect the Escape of Apolipoprotein E from the Endocytic Pathway into the Cytosol and Shows that Direct Expression of Apolipoprotein E in the Cytosol is Cytotoxic , 1999, The Journal of Neuroscience.
[32] Margaret A. Pericak-Vance,et al. Hypothesis: Microtubule Instability and Paired Helical Filament Formation in the Alzheimer Disease Brain Are Related to Apolipoprotein E Genotype , 1994, Experimental Neurology.
[33] R. Demattos,et al. A Minimally Lipidated Form of Cell-derived Apolipoprotein E Exhibits Isoform-specific Stimulation of Neurite Outgrowth in the Absence of Exogenous Lipids or Lipoproteins* , 1998, The Journal of Biological Chemistry.
[34] J. Victoroff,et al. Increased Apolipoprotein E mRNA in the Hippocampus in Alzheimer Disease and in Rats after Entorhinal Cortex Lesioning , 1998, Experimental Neurology.
[35] J. Gilbert,et al. Regionally specific neuronal expression of human APOE gene in transgenic mice , 1998, Neuroscience Letters.
[36] G. Evans,et al. The mouse Thy-1.2 glycoprotein gene: complete sequence and identification of an unusual promoter. , 1986, Journal of immunology.
[37] G. Evans,et al. Expression of the Thy-1 glycoprotein gene by DNA-mediated gene transfer. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[38] H. Braak,et al. Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.
[39] J. Hardy,et al. Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. , 1997, Human molecular genetics.
[40] B. Hyman,et al. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.
[41] H. Geerts,et al. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. , 1999, The American journal of pathology.
[43] K. Horsburgh,et al. Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the rat , 1996, Neuropathology and applied neurobiology.
[44] D. Bonthron,et al. PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model , 1991, Cell.
[45] M. Pericak-Vance,et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[46] K. Jellinger,et al. TAU AND UBIQUITIN IMMUNOREACTIVITY AT DIFFERENT STAGES OF FORMATION OF ALZHEIMER NEUROFIBRILLARY TANGLES , 1989, Progress in clinical and biological research.
[47] L. Serneels,et al. Targeted Inactivation of the Mouse α2-Macroglobulin Gene (*) , 1995, The Journal of Biological Chemistry.
[48] D. Hanger,et al. Neurodegenerative changes including altered tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine/threonine kinase mos , 1996, Neurobiology of Aging.
[49] W. Strittmatter,et al. ApoE genotype and survival from intracerebral haemorrhage , 1995, The Lancet.
[50] J. Brion,et al. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. , 1999, The American journal of pathology.
[51] M. Rossor,et al. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. , 1994, Human molecular genetics.
[52] M. Pericak-Vance,et al. Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease , 1994, Neuroscience Letters.
[53] G. Getz,et al. Effect of Apolipoprotein E on Neurite Outgrowth and β‐Amyloid‐Induced Toxicity in Developing Rat Primary Hippocampal Cultures , 1997, Journal of neurochemistry.
[54] U. Wagner,et al. Tau phosphorylation in transgenic mice expressing glycogen synthase kinase‐3β transgenes , 1997, Neuroreport.
[55] A. Takahashi,et al. Cystatin C and apolipoprotein E immunoreactivities in CA1 neurons in ischemic gerbil hippocampus , 1996, Brain Research.
[56] J. Morris,et al. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia , 1998, Nature Genetics.
[57] A. Messing,et al. GFAP promoter directs astrocyte-specific expression in transgenic mice , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[58] H. Braak,et al. High Frequency of Apolipoprotein E ϵ4 Allele in Young Individuals with Very Mild Alzheimer's Disease-Related Neurofibrillary Changes , 1998, Experimental Neurology.
[59] J. Silver,et al. Regulation of Thy-1 gene expression in transgenic mice , 1987, Cell.
[60] J. Gilbert,et al. Human Apolipoprotein E2, E3, and E4 Isoform-Specific Transgenic Mice: Human-like Pattern of GlialandNeuronal Immunoreactivity in Central Nervous System Not Observed in Wild-Type Mice , 1996, Neurobiology of Disease.
[61] M. Tolar,et al. Neurotoxicity of the 22 kDa Thrombin-Cleavage Fragment of Apolipoprotein E and Related Synthetic Peptides Is Receptor-Mediated , 1997, The Journal of Neuroscience.
[62] G. Getz,et al. Neurons of the Human Frontal Cortex Display Apolipoprotein E Immunoreactivity: Implications for Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.
[63] B. Tycko,et al. Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease , 1995, Neurology.
[64] N. Relkin,et al. Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. , 1997, JAMA.
[65] L. Mucke,et al. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[66] D. Holtzman,et al. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[67] F. Pasquier,et al. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. , 1998, Human molecular genetics.
[68] A. Delacourte,et al. Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE , 1999, Neuroscience Letters.
[69] J. Gilbert,et al. Cis-Acting Human ApoE Tissue Expression Element is Associated with Human Pattern of Intraneuronal ApoE in Transgenic Mice , 1998, Neurobiology of Aging.
[70] A. Fagan,et al. Glial Fibrillary Acidic Protein–Apolipoprotein E (apoE) Transgenic Mice: Astrocyte-Specific Expression and Differing Biological Effects of Astrocyte-Secreted apoE3 and apoE4 Lipoproteins , 1998, The Journal of Neuroscience.
[71] K. Herrup,et al. Expression of Thy-1/lacZ fusion genes in the CNS of transgenic mice. , 1994, Brain research. Molecular brain research.
[72] M. Bullido,et al. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene , 1998, FEBS letters.
[73] A. Roses,et al. Intraneuronal ApoE in human visual cortical areas reflects the staging of Alzheimer disease pathology. , 1998, Journal of neuropathology and experimental neurology.
[74] M. Tolar,et al. A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity. , 1996, Neuroreport.
[75] R. Morris,et al. Thy-1, the enigmatic extrovert on the neuronal surface. , 1992, BioEssays : news and reviews in molecular, cellular and developmental biology.
[76] J. Seidman,et al. Cytoskeletal Changes in the Brains of Mice Lacking Calcineurin Aα , 1997, Journal of neurochemistry.
[77] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[78] R. Martins,et al. The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease. , 1999, Neuroreport.
[79] J. Hardy,et al. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. , 1998, Human molecular genetics.
[80] D. Graham,et al. Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury , 1995, Nature Medicine.
[81] W. White,et al. Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. , 1997, The Annals of thoracic surgery.
[82] K. Latham,et al. Expression of X-linked genes in androgenetic, gynogenetic, and normal mouse preimplantation embryos. , 1995, Developmental genetics.